Vaccitech Company
Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells.
Technology:
Peptides and Proteins, RNA
Industry:
Healthcare
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
12
Total Funding:
79999979
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-03-17
Last Funding Type:
Series B
Register and Claim Ownership